Hetero Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ABACAVIR SULFATE, with a corresponding US DMF Number 22196.
Remarkably, this DMF maintains an Active status since its submission on November 17, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 15, 2013, and payment made on January 24, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II